AERIE PHARMACEUTICALS INC short interest in 2021
In 2021, AERIE PHARMACEUTICALS INC's disclosed short interest ran from 12.33% of shares outstanding on 15 Jan 2021 to 7.24% on 31 Dec 2021, a change of -5.09 percentage points. The year's high was 15.64% on 26 Feb 2021 and its low 7.24% on 31 Dec 2021, averaging 12.45% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 20.42 days on 31 Aug 2021. Full history: AERIE PHARMACEUTICALS INC.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022
2021 in figures
- Start of year
- 12.33% (15 Jan 2021)
- End of year
- 7.24% (31 Dec 2021)
- Change
- -5.09 pp
- High
- 15.64% (26 Feb 2021)
- Low
- 7.24% (31 Dec 2021)
- Average
- 12.45%
- Highest days to cover
- 20.42 (31 Aug 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 12.33% | 14.45 | |
| 29 Jan 2021 | 13.20% | 4.78 | |
| 12 Feb 2021 | 14.99% | 12.01 | |
| 26 Feb 2021 | 15.64% | 15.17 | results (8-K), 10-K filed |
| 15 Mar 2021 | 15.07% | 9.95 | |
| 31 Mar 2021 | 14.94% | 15.34 | |
| 15 Apr 2021 | 13.80% | 15.93 | |
| 30 Apr 2021 | 14.28% | 18.81 | |
| 14 May 2021 | 13.43% | 11.76 | results (8-K), 10-Q filed |
| 28 May 2021 | 13.82% | 16.75 | |
| 15 Jun 2021 | 13.94% | 13.78 | |
| 30 Jun 2021 | 12.99% | 8.29 | |
| 15 Jul 2021 | 11.46% | 13.94 | |
| 30 Jul 2021 | 10.99% | 14.68 | |
| 13 Aug 2021 | 11.05% | 13.48 | results (8-K), 10-Q filed |
| 31 Aug 2021 | 10.62% | 20.42 | |
| 15 Sep 2021 | 11.24% | 10.06 | |
| 30 Sep 2021 | 15.29% | 4.68 | |
| 15 Oct 2021 | 14.34% | 10.34 | |
| 29 Oct 2021 | 12.24% | 6.94 | |
| 15 Nov 2021 | 9.02% | 6.83 | results (8-K), 10-Q filed |
| 30 Nov 2021 | 7.51% | 3.81 | |
| 15 Dec 2021 | 9.46% | 2.27 | |
| 31 Dec 2021 | 7.24% | 2.57 |
See also: AERIE PHARMACEUTICALS INC's full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.